BI-1910pembrolizumabadvanced/metastatic solid tumors
…ing.Conclusions Preliminary dose escalation data are promising. BI-1910 monotherapy shows a favorable safety and tolerability profile, …
1articles mentioning drugs
9drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: BI-1910 ×
BI-1910
This drug is selected. Its supporting articles are shown below.